[Can the carrier of active materials in dragees have a teratogenic effect].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005865:Gestational Age; D005971:Glutamates / Q000494:pharmacology*; D006018:Glycols / Q000494:pharmacology; D008274:Magnesium / Q000494:pharmacology; D010434:Pepsin A / Q000494:pharmacology*; D014677:Pharmaceutical Vehicles / Q000494:pharmacology*; D011095:Polyethylenes / Q000494:pharmacology; D011247:Pregnancy; D011817:Rabbits; D012822:Silicon Dioxide / Q000494:pharmacology; D013213:Starch / Q000494:pharmacology; D013229:Stearic Acids; D013607:Tablets; D013627:Talc / Q000494:pharmacology
D005971:Glutamates; D006018:Glycols; D014677:Pharmaceutical Vehicles; D011095:Polyethylenes; D013229:Stearic Acids; D013607:Tablets; D013627:Talc; D012822:Silicon Dioxide; D013213:Starch; D010434:Pepsin A; D008274:Magnesium
Kann die Trägersubstanz von Wirkstoffen in Dragees eine teratogene Wirkung haben?